SEC Form 4 · accession 0000950103-26-009978
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen Sabzevari
Officer — President and CEO
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2026 | M | 346,836 | $2.33 | A | 4,115,708 | D | |
| Common StockF2 | Jun 29, 2026 | S | 346,836 | $5.89 | D | 3,768,872 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock (Right to Buy)F3 | $2.33 | Jun 29, 2026 | M | 346,836 | D | — | Feb 2, 2032 | Common Stock | 346,836 | 500,164 | D |
Explanation of responses
- F1Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The stock options are fully vested.